ATE509022T1 - Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide - Google Patents

Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide

Info

Publication number
ATE509022T1
ATE509022T1 AT07863786T AT07863786T ATE509022T1 AT E509022 T1 ATE509022 T1 AT E509022T1 AT 07863786 T AT07863786 T AT 07863786T AT 07863786 T AT07863786 T AT 07863786T AT E509022 T1 ATE509022 T1 AT E509022T1
Authority
AT
Austria
Prior art keywords
diazabicycloalkanamide
nicotine
selective
acetylcholine receptor
receptor subtype
Prior art date
Application number
AT07863786T
Other languages
English (en)
Inventor
Anatoly Mazurov
Lan Miao
Yun-De Xiao
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Application granted granted Critical
Publication of ATE509022T1 publication Critical patent/ATE509022T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07863786T 2006-11-02 2007-11-01 Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide ATE509022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85607906P 2006-11-02 2006-11-02
PCT/US2007/083330 WO2008057938A1 (en) 2006-11-02 2007-11-01 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes

Publications (1)

Publication Number Publication Date
ATE509022T1 true ATE509022T1 (de) 2011-05-15

Family

ID=39233054

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10075738T ATE545646T1 (de) 2006-11-02 2007-11-01 Amide von diazabicycloalkanen die selektiv sind für acetylcholin receptor untergruppen
AT07863786T ATE509022T1 (de) 2006-11-02 2007-11-01 Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT10075738T ATE545646T1 (de) 2006-11-02 2007-11-01 Amide von diazabicycloalkanen die selektiv sind für acetylcholin receptor untergruppen

Country Status (32)

Country Link
US (6) US8114889B2 (de)
EP (2) EP2284171B1 (de)
JP (2) JP5539723B2 (de)
KR (2) KR20100124356A (de)
CN (4) CN101528745B (de)
AR (2) AR063451A1 (de)
AT (2) ATE545646T1 (de)
AU (2) AU2007317433B2 (de)
BR (2) BRPI0717930A2 (de)
CA (1) CA2663925C (de)
CL (1) CL2007003155A1 (de)
CO (1) CO6180435A2 (de)
CY (1) CY1112374T1 (de)
DK (1) DK2094703T3 (de)
ES (2) ES2395157T3 (de)
HR (1) HRP20110570T1 (de)
IL (2) IL197618A (de)
MX (1) MX2009004801A (de)
MY (2) MY156730A (de)
NO (1) NO20091251L (de)
NZ (2) NZ587847A (de)
PE (2) PE20081441A1 (de)
PL (1) PL2094703T3 (de)
PT (1) PT2094703E (de)
RS (1) RS51834B (de)
RU (2) RU2448969C2 (de)
SA (1) SA07280584B1 (de)
SI (1) SI2094703T1 (de)
TW (3) TWI405763B (de)
UA (2) UA98944C2 (de)
UY (1) UY30686A1 (de)
WO (1) WO2008057938A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405763B (zh) * 2006-11-02 2013-08-21 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
US20110071180A1 (en) * 2008-03-05 2011-03-24 Targacept, Inc. Sub-type selective amides of diazabicycloalkanes
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
ES2445199T3 (es) 2008-06-05 2014-02-28 Glaxo Group Limited Derivados de benzpirazol como inhibidores de PI3-quinasas
JP5502077B2 (ja) 2008-06-05 2014-05-28 グラクソ グループ リミテッド 新規な化合物
WO2009147189A1 (en) 2008-06-05 2009-12-10 Glaxo Group Limited Novel compounds
WO2010028033A1 (en) * 2008-09-05 2010-03-11 Targacept, Inc. Amides of diazabicyclooctanes and uses thereof
WO2010028011A1 (en) * 2008-09-05 2010-03-11 Targacept, Inc. Amides of diazabicyclononanes and uses thereof
WO2010080757A2 (en) 2009-01-07 2010-07-15 Astrazeneca Ab Combinations with an alpha-4beta-2 nicotinic agonist
US8524751B2 (en) 2009-03-09 2013-09-03 GlaxoSmithKline Intellecutual Property Development 4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
CN102459253B (zh) 2009-04-30 2015-03-25 葛兰素集团有限公司 作为pi3-激酶抑制剂的*唑取代的吲唑化合物
RU2417082C2 (ru) * 2009-07-14 2011-04-27 Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
CA2773409C (en) 2009-11-18 2015-06-16 Suven Life Sciences Limited Bicyclic compounds as .alpha.4.beta.2 nicotinic acetylcholine receptor ligands
MX2012006909A (es) 2009-12-29 2012-07-10 Suven Life Sciences Ltd LIGANDOS DEL RECEPTOR NICOTINICO NEURONAL A4ß2 DE ACETILCOLINA.
GB201018124D0 (en) 2010-10-27 2010-12-08 Glaxo Group Ltd Polymorphs and salts
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
KR20160087900A (ko) 2013-11-26 2016-07-22 에프. 호프만-라 로슈 아게 신규한 옥타하이드로-사이클로부타[1,2-c；3,4-c'']다이피롤-2-일
SI3122750T1 (sl) 2014-03-26 2019-12-31 F. Hoffmann-La Roche Ag Biciklične spojine kot zaviralci proizvodnje avtotaksina (ATX) in lizofosfatidne kisline (LPA)
CN111956803B (zh) 2014-10-20 2025-10-31 奥伊斯特普安生物制药公司 治疗眼部病状的方法
JP6886967B2 (ja) 2015-09-04 2021-06-16 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ フェノキシメチル誘導体
AU2016328365B2 (en) * 2015-09-24 2020-04-23 F. Hoffmann-La Roche Ag New bicyclic compounds as dual ATX/CA inhibitors
CN107635995B (zh) 2015-09-24 2022-08-19 豪夫迈·罗氏有限公司 作为atx抑制剂的二环化合物
RU2018112230A (ru) 2015-09-24 2019-10-30 Ф. Хоффманн-Ля Рош Аг Бициклические соединения в качестве ингибиторов atx
JP6877413B2 (ja) 2015-09-24 2021-05-26 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 二重ａｔｘ／ｃａ阻害剤としての新規な二環式化合物
CN114533737B (zh) 2016-04-07 2024-05-31 奥伊斯特普安生物制药公司 治疗眼部病状的方法
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
EP3596059B1 (de) 2017-03-16 2024-04-24 F. Hoffmann-La Roche AG Als duale atx/ca-inhibitoren nützliche heterocyclische verbindungen
PT3448859T (pt) 2017-03-20 2019-10-25 Forma Therapeutics Inc Composições de pirrolopirrole como ativadores de piruvato quinase (pkr).
ES2989438T3 (es) 2018-09-19 2024-11-26 Novo Nordisk Healthcare Ag Activación de la piruvato cinasa R
US12053458B2 (en) 2018-09-19 2024-08-06 Novo Nordisk Health Care Ag Treating sickle cell disease with a pyruvate kinase R activating compound
CN114615977B (zh) 2019-09-19 2025-01-14 诺沃挪第克健康护理股份公司 丙酮酸激酶r(pkr)活化组合物
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4922901A (en) 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
IL107184A (en) 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5852041A (en) 1993-04-07 1998-12-22 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acethylcholine receptors
US5493026A (en) 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
ATE177099T1 (de) * 1993-12-29 1999-03-15 Pfizer Diazabicyclische neurokinin antagonisten
US5457121A (en) 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5585388A (en) 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
IL118279A (en) 1995-06-07 2006-10-05 Abbott Lab Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
US5726189A (en) 1996-05-03 1998-03-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes
US5952339A (en) 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
JP2003516988A (ja) * 1999-12-14 2003-05-20 ニューロサーチ、アクティーゼルスカブ 新規ヘテロアリール−ジアザビシクロアルカン類
US6809105B2 (en) * 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
CA2440803A1 (en) 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
DK1406900T3 (da) * 2001-07-06 2007-01-29 Neurosearch As Hidtil ukendte forbindelser, fremstilling og anvendelse deraf
SE0202430D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202465D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
CN1317280C (zh) * 2003-02-27 2007-05-23 神经研究公司 新的二氮杂双环芳基衍生物
JP2006519208A (ja) * 2003-02-27 2006-08-24 ニューロサーチ、アクティーゼルスカブ 新規ジアザビシクロアリール誘導体
US7399765B2 (en) * 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
US7365193B2 (en) * 2004-02-04 2008-04-29 Abbott Laboratories Amino-substituted tricyclic derivatives and methods of use
PT1761542E (pt) * 2004-06-09 2008-03-26 Hoffmann La Roche Derivados de octa-hidro-pirrolo[3,4-c) pirrole e o seu uso com agentes antivirais
CA2574307A1 (en) 2004-07-22 2006-02-02 Cumbre Pharmaceuticals Inc. Rifamycin derivatives for treating microbial infections
RU2007146444A (ru) * 2005-05-13 2009-06-20 Лексикон Фармасьютикалз, Инк. (Us) Полициклические соединения и способы их применения
TWI405763B (zh) * 2006-11-02 2013-08-21 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺

Also Published As

Publication number Publication date
CN102838605B (zh) 2017-04-26
RU2517693C2 (ru) 2014-05-27
TW200826935A (en) 2008-07-01
IL197618A (en) 2013-09-30
US8114889B2 (en) 2012-02-14
EP2284171A1 (de) 2011-02-16
JP5739398B2 (ja) 2015-06-24
CN102942569B (zh) 2015-10-28
PL2094703T3 (pl) 2011-10-31
PT2094703E (pt) 2011-07-22
MY145602A (en) 2012-03-15
US8921410B2 (en) 2014-12-30
IL209026A (en) 2014-03-31
AU2007317433B2 (en) 2012-05-10
IL197618A0 (en) 2009-12-24
CN101528745B (zh) 2011-09-14
TWI405763B (zh) 2013-08-21
HK1133260A1 (en) 2010-03-19
RU2009120674A (ru) 2010-12-10
NZ575557A (en) 2011-01-28
TW201305176A (zh) 2013-02-01
KR20090074051A (ko) 2009-07-03
AU2010219323B2 (en) 2012-05-03
CN101528745A (zh) 2009-09-09
NO20091251L (no) 2009-05-28
CL2007003155A1 (es) 2008-05-16
ES2395157T3 (es) 2013-02-08
RU2009138600A (ru) 2011-04-27
CN102020646A (zh) 2011-04-20
US8859609B2 (en) 2014-10-14
NZ587847A (en) 2011-09-30
AR063451A1 (es) 2009-01-28
KR20100124356A (ko) 2010-11-26
AR079840A2 (es) 2012-02-22
US8268860B2 (en) 2012-09-18
ATE545646T1 (de) 2012-03-15
EP2094703B1 (de) 2011-05-11
CN102942569A (zh) 2013-02-27
MX2009004801A (es) 2009-07-31
CA2663925A1 (en) 2008-05-15
TWI404532B (zh) 2013-08-11
JP2013056919A (ja) 2013-03-28
SA07280584B1 (ar) 2010-11-02
IL209026A0 (en) 2011-01-31
MY156730A (en) 2016-03-15
US20120289572A1 (en) 2012-11-15
TW201114424A (en) 2011-05-01
HK1149751A1 (en) 2011-10-14
CA2663925C (en) 2015-04-21
CN102838605A (zh) 2012-12-26
ES2395212T3 (es) 2013-02-11
EP2284171B1 (de) 2012-02-15
US20150080576A1 (en) 2015-03-19
BRPI0722387A2 (pt) 2023-02-23
RS51834B (sr) 2012-02-29
DK2094703T3 (da) 2011-08-29
WO2008057938A1 (en) 2008-05-15
US9580434B2 (en) 2017-02-28
US20100173932A1 (en) 2010-07-08
CY1112374T1 (el) 2015-12-09
UA106718C2 (uk) 2014-10-10
JP2010509230A (ja) 2010-03-25
PE20081441A1 (es) 2008-10-30
RU2448969C2 (ru) 2012-04-27
TWI454262B (zh) 2014-10-01
US20130005789A1 (en) 2013-01-03
JP5539723B2 (ja) 2014-07-02
EP2094703A1 (de) 2009-09-02
AU2010219323A1 (en) 2010-09-30
PE20110671A1 (es) 2011-10-20
UA98944C2 (ru) 2012-07-10
CN102020646B (zh) 2013-11-13
UY30686A1 (es) 2009-08-03
CO6180435A2 (es) 2010-07-19
US20160039833A1 (en) 2016-02-11
BRPI0717930A2 (pt) 2011-05-10
SI2094703T1 (sl) 2011-07-29
HRP20110570T1 (hr) 2011-09-30
US20100081683A1 (en) 2010-04-01
KR101415705B1 (ko) 2014-07-04
AU2007317433A1 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
ATE509022T1 (de) Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide
EP2170350A4 (de) Substituierte imidazoheterocyclen
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
EP2150167A4 (de) Semi-einweg-endoskop
ATE502948T1 (de) Substituierte bicyclolactamverbindungen
BRPI0813500A2 (pt) Compostos antivirais
DK2205737T3 (da) Mikromirer
DK2203462T4 (da) Nukleosid-phosphoramidat-prodrugs
BRPI0821086A2 (pt) Compostos inseticidas
DE602008002772D1 (de) Polyvinylpyrrolidonpulverzusammensetzungen
BRPI0811264A2 (pt) Compostos
BRPI0809996A2 (pt) Compostos
EP2149500A4 (de) Elektronenstrahlensterilisator
EP2211752A4 (de) Biopulpa
BRPI0814424A2 (pt) Compostos heterociclila
FI20075851A0 (fi) Muodostusosa
DE602008005950D1 (de) Münzvereinzeler
EP2208322A4 (de) Grid-router
BRPI0815181A2 (pt) Compostos
EP2195521A4 (de) Kraftstoffdampfabscheider
EP2237903A4 (de) Metallfalzvorrichtung
DE602008001674D1 (de) Wimpernwickler
BRPI0814613A2 (pt) Compostos
LT3825306T (lt) Morfinano junginiai
DE602008000292D1 (de) Werkzeughaltepositioniervorrichtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2094703

Country of ref document: EP